1. Home
  2. HLX vs EYPT Comparison

HLX vs EYPT Comparison

Compare HLX & EYPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Helix Energy Solutions Group Inc.

HLX

Helix Energy Solutions Group Inc.

N/A

Current Price

$9.80

Market Cap

1.4B

Sector

Energy

ML Signal

N/A

EYPT

EyePoint Pharmaceuticals Inc.

N/A

Current Price

$12.50

Market Cap

1.3B

Sector

Industrials

ML Signal

N/A

Company Overview

Basic Information
Metric
HLX
EYPT
Founded
1979
1987
Country
United States
United States
Employees
N/A
N/A
Industry
Oilfield Services/Equipment
Biotechnology: Laboratory Analytical Instruments
Sector
Energy
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
1.4B
1.3B
IPO Year
1996
2005

Fundamental Metrics

Financial Performance
Metric
HLX
EYPT
Price
$9.80
$12.50
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
5
Target Price
$11.50
$31.80
AVG Volume (30 Days)
1.2M
1.5M
Earning Date
04-22-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$876,561,000.00
$7,539,000.00
Revenue This Year
$2.05
N/A
Revenue Next Year
$5.46
$3,115.57
P/E Ratio
N/A
N/A
Revenue Growth
3.60
N/A
52 Week Low
$5.58
$9.41
52 Week High
$10.75
$19.11

Technical Indicators

Market Signals
Indicator
HLX
EYPT
Relative Strength Index (RSI) 63.20 44.20
Support Level $9.21 $11.69
Resistance Level $9.89 $13.32
Average True Range (ATR) 0.28 0.81
MACD 0.09 -0.20
Stochastic Oscillator 92.16 20.48

Price Performance

Historical Comparison
HLX
EYPT

About HLX Helix Energy Solutions Group Inc.

Helix Energy Solutions Group Inc is an offshore energy services company. It provides specialty services to the offshore energy industry, with an emphasis on well intervention and robotics operations. Helix provides services in deep water in the Gulf of Mexico, Brazil, the North Sea, Asia Pacific and West Africa regions. It has four segments: Well Intervention, Robotics, Shallow Water Abandonment and Production Facilities. The Well Intervention segment includes vessels and equipment used to perform well intervention services in the Gulf of Mexico, the North Sea and Brazil. It derives the majority of its revenue from the U.S., and it also has its presence in North Sea, Brazil, Asia Pacific, West Africa, and Other.

About EYPT EyePoint Pharmaceuticals Inc.

EyePoint Inc focuses is a clinical-stage biopharmaceutical company committed to developing and commercializing therapeutics to improve the lives of patients with serious retinal diseases, that may reduce the frequency of follow-up care. The company's pipeline program includes i) DURAVYU: a sustained-release product candidate for retinal diseases, with the potential to provide patients with improved visual outcomes with less burden. ii) EYP-2301: early-stage program using Durasert E technology to deliver razuprotafib, a TIE-2 agonist targeting VE-PTP for vascular stability in retinal diseases like wet AMD.

Share on Social Networks: